Metraipolis › archive › dc_ad8400d583df
Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases — Europe PMC PMID:41304967
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41304967
- DOI
- 10.3390/ph18111723
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T14:27:31.126Z
- SHA-256 of the archived text
7550442f042a69a1c03109deeb7c3c9b81a663fe58a5e51fcacc7038539c62d7- Stable URL of this page
https://metraipolis.com/documento/dc_ad8400d583df
How to cite
Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases — Europe PMC PMID:41304967 — Europe PMC (en), https://europepmc.org/article/MED/41304967 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad8400d583df (Metraipolis archive dc_ad8400d583df, sha256 7550442f042a69a1c03109deeb7c3c9b81a663fe58a5e51fcacc7038539c62d7)
BibTeX
@misc{dcad8400d583df,
title = {Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases — Europe PMC PMID:41304967},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41304967},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad8400d583df; sha256 7550442f042a69a1c03109deeb7c3c9b81a663fe58a5e51fcacc7038539c62d7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304967. Agents can read the archived copy with the MCP tool read_document.